A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors
BeOne Medicines
BeOne Medicines
Seagen Inc.
Eli Lilly and Company
National Institutes of Health Clinical Center (CC)
Eli Lilly and Company
IDEAYA Biosciences
OncoC4, Inc.
Pfizer
IDEAYA Biosciences
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Arcus Biosciences, Inc.
Sotio Biotech Inc.
Pfizer
Rondo Therapeutics
ViroMissile, Inc.
Tizona Therapeutics, Inc
Clasp Therapeutics, Inc.
Baylor College of Medicine
MacroGenics
City of Hope Medical Center
University Health Network, Toronto
NeoTX Therapeutics Ltd.
Actym Therapeutics, Inc.
Jonsson Comprehensive Cancer Center
Incyte Corporation
Trishula Therapeutics, Inc.
Incyte Corporation
Genentech, Inc.
Trishula Therapeutics, Inc.
Monopar Therapeutics
Monopar Therapeutics
Black Diamond Therapeutics, Inc.
Revolution Medicines, Inc.
Seagen Inc.
National Cancer Institute (NCI)
Carisma Therapeutics Inc
Acepodia Biotech, Inc.
Keythera (Suzhou) Pharmaceuticals Co. Ltd
Eli Lilly and Company
Xencor, Inc.
ADC Therapeutics S.A.
Arcus Biosciences, Inc.
Pfizer
STCube, Inc.
Zhejiang University
Adaptimmune
Corvus Pharmaceuticals, Inc.
Rutgers, The State University of New Jersey
Centre Georges Francois Leclerc
Emory University